| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Steep Hill Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.013 |
| 52 Week High | CA$0.09 |
| 52 Week Low | CA$0.003 |
| Beta | 3.61 |
| 1 Month Change | 30.00% |
| 3 Month Change | -31.58% |
| 1 Year Change | 73.36% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -94.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| CD0 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.7% | 1.1% |
| 1Y | 73.4% | -21.6% | 6.5% |
Return vs Industry: CD0 exceeded the German Pharmaceuticals industry which returned -22.6% over the past year.
Return vs Market: CD0 exceeded the German Market which returned 5.9% over the past year.
Price Volatility
| CD0 volatility | |
|---|---|
| CD0 Average Weekly Movement | 72.9% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CD0's share price has been volatile over the past 3 months.
Volatility Over Time: CD0's weekly volatility has decreased from 246% to 73% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 6 | Sameet Kanade | www.steephill.com |
Steep Hill Inc. does not have significant operations. Previously, it operated as a cannabis science company in Canada. The company was formerly known as Cannabis Clonal Corporation and changed its name to Steep Hill Inc. in February 2022.
Steep Hill Inc. Fundamentals Summary
| CD0 fundamental statistics | |
|---|---|
| Market cap | €328.60k |
| Earnings (TTM) | -€297.51k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.1x
P/E RatioIs CD0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CD0 income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$439.44k |
| Earnings | -CA$439.44k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.027 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did CD0 perform over the long term?
See historical performance and comparison